Nalaganje...
BRAF-targeted therapy and immune responses to melanoma
Type I BRAF inhibitors and immunotherapy constitute two new exciting approaches for the treatment of advanced malignant melanoma. We have recently elucidated a role for host C-C chemokine receptor type 2 (CCR2) in the antineoplastic effects of type I BRAF inhibitors in mice, supporting the therapeut...
Shranjeno v:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Landes Bioscience
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3716742/ https://ncbi.nlm.nih.gov/pubmed/23894707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.24462 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|